Filing Details
- Accession Number:
- 0000885590-10-000034
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2010-08-20 14:49:34
- Reporting Period:
- 2010-08-20
- Filing Date:
- 2010-08-20
- Accepted Time:
- 2010-08-20 14:49:34
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 885590 | Biovail Corp | BVF | Pharmaceutical Preparations (2834) | 000000000 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1477126 | Andrew Mark Durham | C/O Biovail Corporation 7150 Mississauga Road Mississauga A6 L5N 8M5 | Svp, Hr & Shared Services | No | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock, No Par Value | Acquisiton | 2010-08-20 | 10,000 | $17.00 | 11,250 | No | 4 | M | Direct | |
| Common Stock, No Par Value | Acquisiton | 2010-08-20 | 50,000 | $17.00 | 61,250 | No | 4 | M | Direct | |
| Common Stock, No Par Value | Disposition | 2010-08-20 | 60,000 | $22.26 | 1,250 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | M | Direct | |
| No | 4 | M | Direct | |
| No | 4 | S | Direct |
Reported Derivative Transactions
| Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
|---|---|---|---|---|---|---|---|
| Common Stock, No Par Value | Stock Options (right to purchase) | Disposition | 2010-08-20 | 10,000 | $0.00 | 10,000 | $17.00 |
| Common Stock, No Par Value | Stock Options (right to purchase) | Disposition | 2010-08-20 | 50,000 | $0.00 | 50,000 | $17.00 |
| Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
|---|---|---|---|---|---|---|
| 0 | 2008-03-01 | 2010-08-20 | No | 4 | M | Direct |
| 0 | 2008-03-01 | 2010-08-20 | No | 4 | M | Direct |
Footnotes
- The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $22.10 to $22.46, inclusive. The reporting person undertakes to provide to Biovail Corporation, any shareholder of Biovail Corporation, or the staff of the Securities and Exchange Commission, in each case upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
Billionaire Hedge Funds
